How about rather than using these vague negative swipes for your own self-interest, you try talking to the data presented. You are suggesting that 60% reduction in mortality is a poor result? Show me your research on this and the current treatment landscape.
Ann: Mesoblast Phase 3 Chronic Heart Failure Results, page-95
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.10 |
Change
-0.028(2.44%) |
Mkt cap ! $1.261B | |||
| Open | High | Low | Value | Volume |
| $1.14 | $1.16 | $1.09 | $4.434M | 3.989M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 24 | 326372 | $1.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.10 | 21814 | 6 |
View Market Depth
| Last trade - 12.41pm 29/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |